StockNews.com assumed coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a research note published on Sunday. The brokerage issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of CO opened at $1.26 on Friday. The firm has a market cap of $152.55 million, a PE ratio of 1.96 and a beta of 0.16. Global Cord Blood has a 1 year low of $2.03 and a 1 year high of $5.50. The stock’s fifty day moving average price is $1.62 and its two-hundred day moving average price is $1.38.
About Global Cord Blood
Featured Articles
- Five stocks we like better than Global Cord Blood
- How to Invest in Blue Chip Stocks
- Goldman Sachs Earnings Reveal Market Moves Investors Can’t Ignore
- Retail Stocks Investing, Explained
- AMD Gains Momentum With AI: Can It Beat Expectations?
- How to Read Stock Charts for Beginners
- Lithium Grab: 2 Lithium Stocks That Could Be Takeover Targets
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.